We are live on
!
Find out more
Tonix Pharmaceuticals
TNXP
TNXP
hedge funds and large institutions have $17.4M invested in Tonix Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
9% less capital invested
Capital invested by funds: $19.1M → $17.4M (-$1.7M)
63% less call options, than puts
Call options by funds: $55K | Put options by funds: $150K
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$55K
Puts
$150K
Net Calls
-$95K
Net Calls Change
-$174K
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$3.17M |
| 2 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$559K |
| 3 |
IAM
Integre Asset Management
New York
|
-$139K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$117K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$82K |
